Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 401: Which antitubercular agent blocks RNA transcription?

A. Rifampicin (Correct Answer)
B. Streptomycin
C. Chloramphenicol
D. Isoniazid

Explanation: **Explanation:** **Correct Answer: A. Rifampicin** Rifampicin is a bactericidal antitubercular drug that acts by inhibiting the **DNA-dependent RNA polymerase** enzyme. By binding to the beta-subunit of this enzyme, it prevents the initiation of RNA synthesis, thereby blocking **RNA transcription**. This mechanism is highly specific to bacterial enzymes, which accounts for its selective toxicity. **Analysis of Incorrect Options:** * **B. Streptomycin:** This is an aminoglycoside that acts by binding to the **30S ribosomal subunit**. It inhibits **protein synthesis** by causing misreading of mRNA and interfering with the initiation complex. * **C. Chloramphenicol:** This is a broad-spectrum antibiotic (not a primary antitubercular agent) that inhibits **protein synthesis** by binding to the **50S ribosomal subunit** and blocking the enzyme peptidyl transferase. * **D. Isoniazid (INH):** This is a prodrug activated by the enzyme *KatG*. It inhibits the synthesis of **mycolic acids**, which are essential components of the mycobacterial cell wall. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Resistance to Rifampicin occurs due to mutations in the **rpoB gene** (encoding the beta-subunit of RNA polymerase). * **Side Effects:** A classic "exam favorite" side effect is the **orange-red discoloration** of body fluids (urine, sweat, tears). It is also a potent **Cytochrome P450 inducer**, leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives and warfarin). * **Mnemonic:** Remember **"R"** for **R**ifampicin, **R**NA polymerase inhibition, and **R**ed-orange secretions.

Question 402: Which of the following tetracyclines can be used in renal failure without dose adjustment?

A. Oxytetracycline
B. Doxycycline (Correct Answer)
C. Minocycline
D. Demeclocycline

Explanation: **Explanation:** The correct answer is **Doxycycline**. **Why Doxycycline is correct:** Most tetracyclines are primarily excreted by the kidneys via glomerular filtration. Therefore, in patients with renal impairment, these drugs accumulate, leading to increased toxicity (including an anti-anabolic effect that worsens azotemia). **Doxycycline** is the notable exception; it is primarily excreted as an inactive chelate via the **feces (biliary excretion)**. Because its clearance is independent of renal function, it is the safest tetracycline for patients with renal failure and requires no dose adjustment. **Why the other options are wrong:** * **Oxytetracycline:** This is a short-acting tetracycline that is highly dependent on renal excretion. It is contraindicated in renal failure. * **Minocycline:** While it undergoes significant hepatic metabolism, it still relies partly on renal clearance. While safer than oxytetracycline, Doxycycline remains the preferred "gold standard" for renal safety. * **Demeclocycline:** This intermediate-acting agent is excreted renally. Notably, it is used clinically to treat SIADH because it induces nephrogenic diabetes insipidus—a side effect that would be dangerous in a patient with pre-existing renal compromise. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Doxycycline is the drug of choice for Chlamydia, Rickettsial infections (Rocky Mountain Spotted Fever), and Lyme disease. * **Storage:** Expired tetracyclines can cause **Fanconi Syndrome** (proximal renal tubular acidosis). * **Contraindications:** Avoid in pregnancy and children <8 years due to bone growth retardation and permanent tooth discoloration. * **Phototoxicity:** Demeclocycline has the highest incidence of phototoxic reactions among tetracyclines.

Question 403: What is the topical antibiotic of choice for MRSA?

A. Mafenide
B. Silver sulfadiazine
C. Mupirocin (Correct Answer)
D. Butenafine

Explanation: **Explanation:** **Mupirocin** is the topical antibiotic of choice for Methicillin-resistant *Staphylococcus aureus* (MRSA). Its unique mechanism of action involves the inhibition of **isoleucyl-tRNA synthetase**, which halts bacterial protein synthesis. Because this mechanism differs from other antibiotic classes, there is minimal cross-resistance. It is primarily used for the eradication of nasal carriage of MRSA in both patients and healthcare workers and is also the first-line treatment for impetigo caused by *S. aureus* or *S. pyogenes*. **Analysis of Incorrect Options:** * **Mafenide & Silver sulfadiazine:** These are topical sulfonamides primarily used in **burn patients**. While they have broad-spectrum activity, their main clinical utility is preventing *Pseudomonas* infections in burn wounds, not targeted MRSA eradication. Mafenide is notable for causing metabolic acidosis (via carbonic anhydrase inhibition). * **Butenafine:** This is a topical **antifungal** agent (benzylamine derivative) used for dermatophytosis (tinea infections). It has no antibacterial activity. **High-Yield Clinical Pearls for NEET-PG:** * **Mupirocin Resistance:** High-level resistance is mediated by the *mupA* gene. * **Nasal Decolonization:** The standard regimen is twice-daily application in the anterior nares for 5 days. * **Alternative for MRSA Decolonization:** If mupirocin resistance is present, topical **Retapamulin** (a pleuromutilin) or **Povidone-iodine** may be used. * **Systemic MRSA:** For systemic infections, the drugs of choice are Vancomycin, Linezolid, or Daptomycin.

Question 404: All of the following statements about penicillin-binding proteins are true EXCEPT:

A. Present on the cell surface
B. Mutation in PBPs gives rise to resistance
C. They are target sites of vancomycin
D. Methicillin-resistant Staphylococcus aureus (MRSA) has acquired a PBP with very high affinity for beta-lactam antibiotics. (Correct Answer)

Explanation: **Explanation:** The correct answer is **Option D** because it contains a false statement. **MRSA** resistance is mediated by the acquisition of the *mecA* gene, which encodes a modified penicillin-binding protein called **PBP2a**. This PBP2a has a **very low affinity** (not high) for almost all beta-lactam antibiotics, allowing the bacteria to continue cell wall synthesis even in the presence of these drugs. **Analysis of other options:** * **Option A:** PBPs are enzymes (transpeptidases) located on the **outer surface of the cytoplasmic membrane**. They are essential for the cross-linking of peptidoglycan chains in the bacterial cell wall. * **Option B:** Mutations in PBPs are a classic mechanism of resistance. For example, **Penicillin-resistant Streptococcus pneumoniae (PRSP)** develops resistance through structural alterations in its native PBPs. * **Option C:** This is a common distractor. While PBPs are the targets for **Beta-lactams**, **Vancomycin** does not bind to PBPs. Instead, it binds to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, sterically hindering the PBP from performing its cross-linking function. (Note: In some exam contexts, if the question asks for the "target site of action," Vancomycin's target is the substrate, not the enzyme). **Clinical Pearls for NEET-PG:** * **MRSA Treatment:** Since PBP2a has low affinity for most beta-lactams, the drugs of choice are **Vancomycin** or **Linezolid**. * **Exception:** **Ceftaroline** (5th generation cephalosporin) is the only beta-lactam that has a high enough affinity for PBP2a to be effective against MRSA. * **Mechanism Summary:** Beta-lactams = Bind to Enzyme (PBP); Vancomycin = Binds to Substrate (D-Ala-D-Ala).

Question 405: Which anti-tubercular drug is generally not given in patients with liver disease?

A. Isoniazid
B. Ethambutol
C. Pyrazinamide (Correct Answer)
D. Rifampicin

Explanation: **Explanation:** The management of tuberculosis in patients with pre-existing liver disease requires careful selection of drugs, as three out of the four first-line agents are hepatotoxic. **Why Pyrazinamide is the correct answer:** Pyrazinamide (PZA) is considered the **most hepatotoxic** of all first-line anti-tubercular drugs (ATDs). It causes dose-dependent hepatotoxicity and can lead to prolonged liver injury. According to standard guidelines (WHO/RNTCP), if a patient has unstable or advanced chronic liver disease, Pyrazinamide is the first drug to be excluded from the regimen to prevent fulminant hepatic failure. **Analysis of Incorrect Options:** * **Isoniazid (INH):** While INH is hepatotoxic (causing idiosyncratic hepatitis), it is often retained in modified regimens for liver disease unless the liver injury is severe, as its therapeutic benefit is high. * **Rifampicin:** It is also hepatotoxic and can cause transient cholestatic jaundice. However, it is less hepatotoxic than Pyrazinamide and is usually the backbone of "liver-safe" regimens (e.g., 2HRE + 7HR). * **Ethambutol:** This is the correct choice for patients with liver disease because it is **not hepatotoxic**. It is primarily excreted by the kidneys. **NEET-PG High-Yield Pearls:** 1. **Hepatotoxicity Order:** Pyrazinamide > Isoniazid > Rifampicin. 2. **Safe Drugs in Liver Disease:** Ethambutol and Streptomycin (neither is metabolized by the liver). 3. **Regimen for Stable Chronic Liver Disease:** If the liver is compensated, a regimen like **2HRE + 7HR** (avoiding Pyrazinamide) is commonly used. 4. **Monitoring:** If ALT/AST levels rise >3 times the upper limit of normal with symptoms, or >5 times without symptoms, all hepatotoxic drugs must be stopped immediately.

Question 406: Tetracyclines are the first drug of choice for which of the following conditions EXCEPT?

A. Granuloma inguinale
B. Cholera
C. Atypical pneumonia
D. Community-acquired pneumonia (Correct Answer)

Explanation: **Explanation:** Tetracyclines (specifically Doxycycline) are highly effective against a variety of intracellular and atypical pathogens. However, they are **not** the first-line treatment for **Community-Acquired Pneumonia (CAP)** in general clinical practice. **1. Why Community-Acquired Pneumonia (CAP) is the correct answer:** According to current IDSA/ATS guidelines, the first-line treatment for outpatient CAP is typically **Amoxicillin** (high dose) or **Macrolides** (like Azithromycin, if resistance is low). While Doxycycline is an acceptable alternative, it is not the primary "drug of choice" because CAP is most commonly caused by *Streptococcus pneumoniae*, for which beta-lactams remain the gold standard. **2. Why the other options are incorrect (Conditions where Tetracyclines ARE the drug of choice):** * **Granuloma Inguinale (Donovanosis):** Caused by *Klebsiella granulomatis*. Doxycycline (100 mg BID for 3 weeks) is the first-line treatment. * **Cholera:** Doxycycline is the drug of choice for *Vibrio cholerae* as it reduces the volume of stool and shortens the duration of diarrhea. * **Atypical Pneumonia:** Doxycycline is a primary choice for pneumonia caused by *Mycoplasma pneumoniae*, *Chlamydia pneumoniae*, and *Legionella* (though macrolides/quinolones are also used). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Tetracycline DOC:** "**R**ick **C**hose **L**ove **G**ranually" (**R**ickettsial infections, **C**holera, **L**yme disease/Lymphogranuloma venereum, **G**ranuloma inguinale). * **Rickettsial Diseases:** Doxycycline is the DOC for all Rickettsial infections (Rocky Mountain Spotted Fever, Q fever, Scrub typhus), regardless of age. * **Contraindications:** Avoid in pregnancy and children <8 years due to permanent teeth discoloration and bone growth suppression (except in life-threatening Rickettsial infections). * **Excretion:** Doxycycline is the safest tetracycline in renal failure because it is excreted primarily via feces (enterohepatic circulation).

Question 407: Cidofovir can be used for which of the following conditions?

A. Respiratory papillomatosis
B. Herpes simplex
C. Herpes zoster
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Cidofovir** is a potent acyclic nucleoside phosphonate analog that acts as a broad-spectrum antiviral agent. Unlike acyclovir, it is already phosphorylated (a nucleotide analog), meaning it does not require activation by viral kinases (like thymidine kinase). This allows it to remain effective against resistant viral strains. 1. **Why "All of the above" is correct:** * **Respiratory Papillomatosis:** Cidofovir is highly effective against Human Papillomavirus (HPV). It is used off-label via intralesional injection to treat recurrent respiratory papillomatosis, significantly reducing the frequency of surgical debridements. * **Herpes Simplex (HSV) & Herpes Zoster (VZV):** While not first-line, Cidofovir is indicated for mucocutaneous HSV and VZV infections, particularly in immunocompromised patients where the virus has developed resistance to Acyclovir or Foscarnet. 2. **Analysis of Options:** * **Option A:** Correct. It inhibits HPV DNA polymerase and induces apoptosis in HPV-infected cells. * **Option B & C:** Correct. It inhibits the DNA polymerase of almost all DNA viruses, including the entire Herpesviridae family (HSV, VZV, CMV, EBV, and HHV-8). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Competitive inhibition of viral DNA polymerase; it incorporates into the growing DNA chain, causing chain termination. * **Primary Indication:** CMV retinitis in HIV/AIDS patients. * **Dose-Limiting Toxicity:** **Nephrotoxicity** (proximal tubular damage). * **Prevention of Toxicity:** Must be administered with **Oral Probenecid** and aggressive **IV Saline hydration** to reduce uptake into proximal tubule cells and minimize kidney damage. * **Spectrum:** Broad DNA virus coverage including Poxvirus (Molluscum contagiosum), Adenovirus, and Polyomavirus (BK virus).

Question 408: What is the recommended dose of Artemether for severe malaria?

A. 1.2 mg/Kg
B. 1.7 mg/kg
C. 2.4 mg/kg (Correct Answer)
D. 3.4 mg/kg

Explanation: **Explanation:** The management of severe malaria (caused primarily by *Plasmodium falciparum*) is a critical high-yield topic for NEET-PG. According to the WHO and National Vector Borne Disease Control Programme (NVBDCP) guidelines, **Artesunate** (an artemisinin derivative) is the drug of choice for severe malaria. **Why 2.4 mg/kg is correct:** The standard dosing regimen for intravenous or intramuscular Artesunate is **2.4 mg/kg body weight** given at 0, 12, and 24 hours, followed by once-daily administration until the patient can tolerate oral medication. This dose is optimized to achieve rapid parasite clearance and reduce mortality compared to older drugs like Quinine. **Analysis of Incorrect Options:** * **1.2 mg/kg:** This is half the standard dose and would result in sub-therapeutic levels, leading to treatment failure and potential drug resistance. * **1.6 - 1.7 mg/kg:** While not the standard for Artesunate, 1.6 mg/kg is sometimes associated with the maintenance dose of *Artemether* (a different derivative) when used in specific oily IM formulations, but it is not the primary recommendation for severe malaria management in this context. * **3.2 - 3.4 mg/kg:** This is typically the **loading dose** for intramuscular **Artemether** (3.2 mg/kg), not Artesunate. Using this dose for Artesunate could increase the risk of dose-related toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** IV Artesunate is preferred over IV Quinine because it is easier to administer, does not require cardiac monitoring, and does not cause hypoglycemia. * **Follow-up:** Once the patient can swallow, a full 3-day course of **ACT (Artemisinin-based Combination Therapy)** must be completed to ensure total parasite clearance. * **Side Effect:** Watch for **Post-Artesunate Delayed Hemolysis (PADH)**, which can occur 1–3 weeks after treatment. * **Pregnancy:** IV Artesunate is safe and recommended for severe malaria in all trimesters of pregnancy.

Question 409: What is the drug of choice for cerebral malaria caused by Plasmodium falciparum?

A. Chloroquine
B. Quinine (Correct Answer)
C. Mefloquine
D. Sulfadoxine + Pyrimethamine

Explanation: **Explanation:** **Cerebral malaria** is a medical emergency characterized by impaired consciousness and multi-organ involvement. The primary goal of treatment is rapid clearance of parasitemia. **Why Quinine is the Correct Answer:** Historically and traditionally, **intravenous Quinine** has been the drug of choice for severe/cerebral malaria. It is a rapidly acting schizonticide that acts by inhibiting heme polymerase, leading to the accumulation of toxic heme within the parasite. While the WHO now recommends **Artesunate** as the first-line treatment globally due to better survival outcomes and fewer side effects, Quinine remains the classic "textbook" answer in many Indian medical examinations (unless Artesunate is provided as an option). **Analysis of Incorrect Options:** * **A. Chloroquine:** Once the gold standard, it is no longer used for *P. falciparum* due to widespread high-level resistance (CQR). It remains the drug of choice only for sensitive *P. vivax*. * **C. Mefloquine:** Used primarily for prophylaxis in travelers or as part of combination therapy for uncomplicated malaria. It is not used for cerebral malaria due to its slow onset and potential for neuropsychiatric side effects. * **D. Sulfadoxine + Pyrimethamine:** This is a slow-acting antifolate combination used for uncomplicated malaria. It is never used as monotherapy for severe malaria. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice (Updated):** If both are listed, **IV Artesunate** is now preferred over IV Quinine (WHO & NVBDCP guidelines). 2. **Quinine Toxicity:** Watch for **Cinchonism** (tinnitus, deafness, headache, blurred vision) and **hypoglycemia** (due to stimulation of pancreatic beta cells). 3. **Blackwater Fever:** A rare complication of Quinine therapy involving massive intravascular hemolysis and hemoglobinuria. 4. **Loading Dose:** Quinine must be administered with a loading dose to reach therapeutic levels rapidly, followed by a maintenance infusion.

Question 410: Which of the following is NOT a mechanism of resistance to erythromycin?

A. Alteration in ribosomal binding site
B. Plasmid mediated
C. Erythromycin esterase production (Correct Answer)
D. Efflux proteins

Explanation: **Explanation:** Erythromycin belongs to the **Macrolide** class of antibiotics, which act by binding to the 50S ribosomal subunit, inhibiting protein synthesis [1]. Resistance to macrolides is common and occurs through three primary mechanisms: 1. **Target Site Modification (Option A):** This is the most important mechanism. It involves the methylation of the 23S rRNA of the 50S subunit by an enzyme called **methylase** (encoded by the *erm* gene). This prevents the drug from binding [2]. 2. **Efflux Pumps (Option D):** Bacteria can acquire an active efflux mechanism (encoded by the *mef* gene) that pumps the drug out of the cell, reducing its intracellular concentration [2]. 3. **Genetic Transfer (Option B):** Most resistance genes (like *erm* or *mef*) are carried on **plasmids** or transposons, allowing rapid spread between bacteria [1]. **Why Option C is the Correct Answer:** **Erythromycin esterase** production is a mechanism of resistance specifically associated with **Gram-negative bacilli** (like *E. coli*) against certain macrolides, but it is **not** a standard or clinically significant mechanism for the resistance typically encountered in the pathogens erythromycin is intended to treat (like Gram-positive cocci). In the context of NEET-PG, esterases are more famously associated with resistance to drugs like chloramphenicol (acetyltransferase) or aminoglycosides (modifying enzymes), rather than being a primary mechanism for erythromycin. **High-Yield Clinical Pearls for NEET-PG:** * **MLS_B Resistance:** Methylation of the ribosome causes cross-resistance between **M**acrolides, **L**incosamides (Clindamycin), and **S**treptogramin **B**. * **Ketolides (Telithromycin):** Designed specifically to overcome macrolide resistance because they have a higher affinity for the 50S subunit and do not induce methylase enzymes. * **Motilin Agonist:** Erythromycin is often used off-label for gastroparesis because it stimulates motilin receptors.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free